Share on LinkedInShare on LinkedIn

ARTICLE · 17 JULY 2025

Non-Consensual Releases In Boy Scouts Chapter 11 Plan Survive Despite Purdue Pharma Ruling

A&O Shearman
A&O Shearman
Contributor

A&O Shearman

Introducing A&O Shearman Unparalleled global depth for a changing world. Today more than ever,...

View firm profile
Explore more from A&O Shearman

The Supreme Court's landmark 2024 Purdue Pharma decision altered the landscape for bankruptcy releases and, in the process, put the resolutions of several other pending mass tort chapter 11 cases in question.

United StatesInsolvency/Bankruptcy/Re-Structuring

The Supreme Court's landmark 2024 Purdue Pharma decision altered the landscape for bankruptcy releases and, in the process, put the resolutions of several other pending mass tort chapter 11 cases in question.

A recent decision by the Third Circuit Court of Appeals held that the chapter 11 plan of Boy Scouts of America (Boy Scouts), which featured a sale of insurance policies back to insurers to fund a trust for the benefit of tort victims, was protected from review on appeal by section 363(m) of the Bankruptcy Code, even though the transaction included non-consensual third-party releases, which the Supreme Court, held to be impermissible in Purdue Pharma.1 The Third Circuit's decision demonstrates how section 363(m) can provide powerful and broad protection to all aspects of a sale bargain, including monetary and non-monetary consideration, like third party releases.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from